Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Non-cash Items (2019 - 2025)

Beam Therapeutics (BEAM) has disclosed Non-cash Items for 7 consecutive years, with $7.4 million as the latest value for Q4 2025.

  • Quarterly Non-cash Items fell 80.16% to $7.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.4 million through Dec 2025, down 80.16% year-over-year, with the annual reading at $7.4 million for FY2025, 25.13% up from the prior year.
  • Non-cash Items for Q4 2025 was $7.4 million at Beam Therapeutics, up from $7.1 million in the prior quarter.
  • The five-year high for Non-cash Items was $300.6 million in Q4 2021, with the low at $1.7 million in Q2 2021.
  • Average Non-cash Items over 5 years is $75.4 million, with a median of $65.5 million recorded in 2021.
  • The sharpest move saw Non-cash Items skyrocketed 8631.92% in 2022, then crashed 97.53% in 2023.
  • Over 5 years, Non-cash Items stood at $300.6 million in 2021, then tumbled by 63.07% to $111.0 million in 2022, then tumbled by 53.46% to $51.7 million in 2023, then dropped by 28.02% to $37.2 million in 2024, then plummeted by 80.16% to $7.4 million in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $7.4 million, $7.1 million, and $6.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.